Skip to main content
. 2023 Jan 21;29(3):487–502. doi: 10.3748/wjg.v29.i3.487

Table 3.

Drugs and vaccines used in the management and prevention of coronavirus disease 19

Classification
Drugs
Antiviral agents Favipiravir, molnupiravir, paxlovid, remdesivir
Immunomodulatory agents
JAK inhibitors Baricitinib, ruxolitinib, tofacitinib
Monoclonal antibodies to IL-6 Sarilumab, tocilizumab
Corticosteroids Cortisol, dexamethasone, methylprednisolone
Monoclonal antibodies to SARS-CoV-2 Bamlanivimab, casirivimab, etesevimab, imdevimab, sotrovimab
COVID-19 vaccines
mRNA BNT162b2 [Pfizer-BioNTech], mRNA-1273 [Moderna]
Adenovirus vector ChAdOx1-S [AstraZeneca, Oxford]; Ad26.COV2.S [Johnson and Johnson, Janssen], Sputnik-V-Gam - COVID Vac Ad5+Ad26 [Gamleaya]
Recombinant nanoparticles NVX-CoV2373 [Novavax]
Miscellaneous agents Azithromycin, chloroquine, dexamethasone, fluvoxamine, hydroxychloroquine, ivermectin

COVID-19: Coronavirus disease 19; IL-6: Interleukin-6; SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2.